09 March 2020

GSK Stockmann advised Aroundtown SA on the successful voluntary public takeover offer to the shareholders of TLG Immobilien AG

GSK Stockmann (Luxembourg) advised Aroundtown SA, the largest listed German commercial real estate company, in connection with the voluntary public takeover offer to the shareholders of TLG Immobilien AG in all matters relating to Luxembourg law.

The Luxembourg office of GSK Stockmann provided corporate and capital markets legal advice, in particular on the prospectus and the offer document regarding the voluntary public takeover offer. The team around Dr. Philipp Mössner assisted with the future set-up of the new corporate governance structure and led the EUR 2.4 billion capital increase of Aroundtown in connection with the share for share exchange.

The business combination of Aroundtown SA with TLG Immobilien AG created a leading pan-European real estate company with a well-diversified office/hotel/residential portfolio.

GSK Stockmann (Luxembourg) has been advising Aroundtown SA for several years. Previous advice included, among others, Aroundtown’s successful migration from Cyprus to Luxembourg in 2017 and the offer of a scrip dividend in 2018 and 2019.

Legal advisors to Aroundtown SA:

GSK Stockmann (Luxembourg law): Dr. Philipp Mössner (lead partner: Corporate/Capital Markets); associates: Anna Lindner, Chara Papagiannidi, Andrea Carraretto, Julie Nys (all Corporate/Capital Markets)

Taylor Wessing (German law): Marc-Oliver Kurth, Dr. Sebastian Klabunde, Ulrich Reers

Greenberg Traurig (US law): Dorothee Fischer-Appelt

Legal advisors to TLG Immobilien AG:

Sullivan & Cromwell (German law): Dr. Carsten Berrar, Florian Späth

Arendt & Medernach (Luxembourg law): Carsten Opitz

Legal advisors to Deutsche Bank AG and J.P. Morgan: Linklaters (German, Luxembourg and US law): Dr. Alexander Schlee, Ulli Janssen, Rémy Bonneau


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 30.11.2020

    GSK Update: Sustainability-Linked Bonds: Linking Business Strategy with Sustainability

    Read more
  • 17.09.2020

    GSK Update: Cross-Border Conversions within the EU are bound for Change: Main Takeaways

    Read more
  • 29.07.2020

    GSK Update: Latest Developments on the Proposed Legalization and Regulation of Cannabis

    Read more
Contact person

Dr. Philipp Mössner, LL.M.


+352 271802-40


Anna Lindner

Senior Associate

+352 271802-43


Chara Papagiannidi, LL.M.


+352 271802-91


Andrea Carraretto, LL.M.


+352 271802-42


Julie Nys, LL.M.


+352 271802-41


© GSK Stockmann 2021